In short
This article explores the use of Febuxostat Hemihydrate in clinical trials, specifically focusing on a study comparing different urate-lowering therapies for gout treatment. The trial aims to assess the effectiveness of continuing versus stopping these therapies in patients with gout in remission, providing valuable insights into optimal treatment strategies and their cost-effectiveness.
At a glance
- Study Title
- GOut TrEatment STrategy (GO TEST) FINALE study
- Main Objective
- Compare continuation vs. cessation of urate-lowering therapies in gout remission
- Medications Studied
- Allopurinol, Benzbromarone, Febuxostat Hemihydrate
- Study Duration
- 24 months
- Primary Endpoint
- Proportion of patients maintaining gout remission
- Key Inclusion Criteria
- Gout diagnosis, ULT use, achieved remission for ≥12 months, age ≥18 years
- Key Exclusion Criteria
- Language barriers, life expectancy <2 years, contraindications for flare treatments
- Febuxostat Hemihydrate Details
- Max daily dose: 120 mg, Route: Oral, Treatment period: up to 24 months
What is Febuxostat?
Febuxostat hemihydrate, commonly known as Febuxostat, is a medication used in the treatment of gout. It belongs to a class of drugs called xanthine oxidase inhibitors. Febuxostat is considered a urate-lowering therapy (ULT), which means it helps reduce the levels of uric acid in the body.
How Does Febuxostat Work?
Febuxostat works by blocking an enzyme called xanthine oxidase. This enzyme is responsible for producing uric acid in the body. By inhibiting this enzyme, Febuxostat helps to lower the amount of uric acid in the blood, which is the primary cause of gout symptoms.
Uses of Febuxostat
The primary use of Febuxostat is in the treatment of gout. Gout is a form of arthritis caused by the buildup of uric acid crystals in the joints, leading to pain, swelling, and inflammation. Febuxostat is typically prescribed for patients who have been diagnosed with gout and need long-term management of their uric acid levels.
Dosage Information
According to the clinical trial information, the maximum daily dose of Febuxostat is 120 mg. However, it's important to note that dosage can vary depending on individual patient needs and should always be determined by a healthcare professional.
Current Clinical Trial: GO TEST FINALE Study
Febuxostat is currently being studied in a clinical trial called the GO TEST FINALE study. This trial is comparing different treatment strategies for gout patients who have achieved remission.
Key points about the study:
- It's comparing the continuation versus cessation of urate-lowering therapies (including Febuxostat) in gout patients who have achieved remission.
- The study aims to determine which strategy is more effective in maintaining gout remission over a 24-month period.
- Participants in the study have been in gout remission for at least 12 months, meaning they've been free of gout flares and visible tophi (uric acid deposits under the skin).
- The study is also looking at the cost-effectiveness of different treatment strategies.
Important Considerations for Patients
If you're considering or currently taking Febuxostat, here are some important points to keep in mind:
- Long-term use: Febuxostat is typically used as a long-term treatment for gout. The clinical trial is studying its use over a 24-month period.
- Monitoring: While on Febuxostat, your doctor will likely monitor your uric acid levels regularly to ensure the medication is effective.
- Gout flares: When starting Febuxostat, you might experience an increase in gout flares initially. This is normal and doesn't mean the medication isn't working. Your doctor may prescribe additional medications to manage these flares.
- Other medications: Febuxostat may be used alongside other gout medications like colchicine, NSAIDs, or prednisone for flare management.
- Cardiovascular health: If you have a history of heart problems, especially recent heart attack or stroke, make sure to discuss this with your doctor before starting Febuxostat.
Remember, Febuxostat is a prescription medication and should only be taken under the guidance of a healthcare professional. Always follow your doctor's instructions regarding dosage and report any side effects or concerns you may have.